Gemetastaseerd plaveiselcelcarcinoom na niertransplantatie

Transplant patients have a higher risk of developing advanced cutaneous squamous cell carcinoma. In case of metastasized or locally advanced disease when curative surgery or radiotherapy is not possible, immune therapy is an option. However, there is a risk of organ rejection due to boosted immune response. We describe a case where complete remission of cutaneous squamous cell carcinoma with pulmonary metastasis in a kidney transplant patient has been achieved with cemiplimab with preservation of transplant function.